Bluejay Diagnostics Secures $7.7M Net in Private Placement, Issues Warrants
BJDX has more than doubled off its 52-week low of $1.623 on light trading volume (0.1× avg).
Summary
Bluejay Diagnostics has completed a private placement, raising $7.7 million in net proceeds through the issuance of pre-funded and 5-year warrants. This capital infusion is critical for the company, which reported only $3.7 million in cash and a going concern warning in its May 7th 10-Q filing, indicating a need for $20 million by 2027. The closing of this private placement was previously announced on June 6th, with an initial figure of $8.5 million gross proceeds, and detailed in an 8-K filed earlier today. While the funds provide immediate liquidity, the company still needs to secure additional financing to meet its long-term capital requirements.
At the time of this announcement, BJDX was trading at $5.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.4M. The 52-week trading range was $1.62 to $16.68. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.